White Papers

  1. Achieving Harmonious and Optimized Site Budget Negotiations 4/13/2023

    Review findings from research efforts into how principal investigators survive the complex process, identify coping strategies, and combat budget negotiation challenges.

  2. The State Of Black Participation In Clinical Trials 2/24/2023

    The need to design trials enrolling more demographically diverse patients is widely recognized. Learn why implementing effective, sustainable, and scalable enrollment diversity strategies remains a challenge for biopharmaceutical companies.

  3. Synthetic Control Arm In Clinical Trials 12/8/2022

    Get an overview of the SCA, an external control generated with the goal of improving the interpretation of uncontrolled trials, which can enable better product development decisions.

  4. Site Perspectives On Decentralized Clinical Trials 11/15/2022

    Discover why understanding clinical research sites’ experiences and perspectives on DCTs will help industry stakeholders  refine trial design, operational procedures, and regulatory policy to better serve patients and sites.

  5. Hassle-Free Imaging In Clinical Trials 6/14/2022

    In this paper, writers ask readers to consider how far the field of imaging has transpired in recent times, as well as explore the latest innovations, and contemplate what possibilities lie ahead.

  6. Insights Into Clinical Trial Enrollment 5/18/2022

    Explore the continued impact of the pandemic on clinical trial enrollment in Phase II and III studies to help the industry navigate the dynamic landscape in 2022 across four therapeutic areas (TAs).

  7. Characterizing The Use Of External Controls For Augmenting Randomized Control Arms And Confirming Benefit 4/19/2022

    Learn several approaches to constructing an external control while considering the use of hybrid designs that supplement or augment the control group in the randomized control trials (RCT) with data from an external population.

  8. DCTs: What Are They And What Are The Direct Impacts To DMs? 1/21/2022

    In 2020, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future. 

  9. Advancing DCTs Through A Unified Approach To eCOA And DHTs 7/6/2021

    Digital health technologies and assessments of patient-reported outcomes are on the rise. Read how uniting the two can better inform how patients experience their disease and respond to treatment.

  10. Transform Your Drug Safety Data And Adjudication Processes With Technology 7/6/2021

    Many may not know that cloud platforms can help streamline clinical endpoint adjudication. Read below to see how these play a role in cutting costs, improving data quality, smoothing regulatory approval, and speeding time to market.